Actively Recruiting
Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)
Led by Samsung Medical Center · Updated on 2025-06-29
400
Participants Needed
1
Research Sites
555 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.
CONDITIONS
Official Title
Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed breast cancer
- Presence of distant metastasis
- Radiation therapy using IMRT, SBRT, or proton therapy is done or planned
- Able and willing to comply with the study protocol
You will not qualify if you...
- Unable to adhere to the study protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Samsung Medical Center
Seoul, South Korea
Actively Recruiting
Research Team
H
Haeyoung Kim
CONTACT
W
won kyung Cho
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here